Immunocore Holdings plc - ADR (IMCR)

CUSIP: 45258D105

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class
Equity / ADR
Shares outstanding
50,698,400
Total 13F shares
43,068,701
Share change
+1,862,436
Total reported value
$1,459,854,294
Put/Call ratio
69%
Price per share
$33.89
Number of holders
135
Value change
-$99,787,937
Number of buys
80
Number of sells
69

Quarterly Holders Quick Answers

What is CUSIP 45258D105?
CUSIP 45258D105 identifies IMCR - Immunocore Holdings plc - ADR in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of IMCR - Immunocore Holdings plc - ADR (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
RTW INVESTMENTS, LP
13F
Company
12%
6,019,641
$391,276,665 31 Mar 2024
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
11%
5,747,270
$373,572,550 31 Mar 2024
13F
FMR LLC
13F
Company
8.5%
4,312,144
$280,289,361 31 Mar 2024
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
4.8%
2,437,584
$158,443,000 31 Mar 2024
13F
Rock Springs Capital Management LP
13F
Company
4.7%
2,367,816
$153,908,040 31 Mar 2024
13F
Paradigm Biocapital Advisors LP
13F
Company
3.5%
1,787,176
$116,166,440 31 Mar 2024
13F
BAKER BROS. ADVISORS LP
13F
Company
3%
1,515,318
$98,495,670 31 Mar 2024
13F
GENERAL ATLANTIC, L.P.
13F
Individual
3%
1,506,684
$97,934,460 31 Mar 2024
13F
Bellevue Group AG
13F
Company
1.9%
972,254
$63,196,510 31 Mar 2024
13F
Logos Global Management LP
13F
Company
1.8%
900,000
$58,500,000 31 Mar 2024
13F
BlackRock Finance, Inc.
13F
Company
1.7%
867,357
$56,378,205 31 Mar 2024
13F
Fiera Capital Corp
13F
Company
1.7%
866,412
$56,316,780 31 Mar 2024
13F
MORGAN STANLEY
13F
Company
1.6%
801,275
$52,082,909 31 Mar 2024
13F
T. Rowe Price Investment Management, Inc.
13F
Company
1.4%
733,611
$47,685,000 31 Mar 2024
13F
Pictet Asset Management Holding SA
13F
Company
1.4%
706,607
$45,929,455 31 Mar 2024
13F
Gates Foundation
13F
Company
1.1%
576,923
$37,499,995 31 Mar 2024
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
1.1%
564,800
$36,712,000 31 Mar 2024
13F
PRINCIPAL FINANCIAL GROUP INC
13F
Company
1%
517,204
$33,618,260 31 Mar 2024
13F
Polar Capital Holdings Plc
13F
Company
0.99%
501,300
$32,584,500 31 Mar 2024
13F
TANG CAPITAL MANAGEMENT LLC
13F
Company
0.8%
405,600
$26,364,000 31 Mar 2024
13F
First Turn Management, LLC
13F
Company
0.78%
394,674
$25,653,810 31 Mar 2024
13F
BNP Paribas Asset Management Holding S.A.
13F
Company
0.67%
342,000
$22,230,000 31 Mar 2024
13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/
13F
Company
0.61%
311,121
$20,222,865 31 Mar 2024
13F
Avidity Partners Management LP
13F
Company
0.56%
286,400
$18,616,000 31 Mar 2024
13F
Woodline Partners LP
13F
Company
0.54%
274,038
$17,812,470 31 Mar 2024
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.53%
267,787
$17,406,155 31 Mar 2024
13F
JANUS HENDERSON GROUP PLC
13F
Company
0.51%
257,080
$16,711,485 31 Mar 2024
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.49%
248,468
$16,150,420 31 Mar 2024
13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC
13F
Company
0.43%
218,892
$14,227,980 31 Mar 2024
13F
MARSHALL WACE, LLP
13F
Company
0.43%
217,951
$14,166,815 31 Mar 2024
13F
TD ASSET MANAGEMENT INC
13F
Company
0.42%
215,014
$13,975,910 31 Mar 2024
13F
THRIVENT FINANCIAL FOR LUTHERANS
13F
Company
0.42%
213,990
$13,909,000 31 Mar 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.4%
203,949
$13,256,685 31 Mar 2024
13F
S.c.a. Candriam
13F
Individual
0.37%
189,006
$12,285,390 31 Mar 2024
13F
ARMISTICE CAPITAL, LLC
13F
Company
0.32%
164,000
$10,660,000 31 Mar 2024
13F
D. E. Shaw & Co., Inc.
13F
Company
0.28%
140,094
$9,106,110 31 Mar 2024
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.27%
135,649
$8,817,185 31 Mar 2024
13F
Artisan Partners Limited Partnership
13F
Company
0.25%
126,610
$8,229,650 31 Mar 2024
13F
COWEN AND COMPANY, LLC
13F
Company
0.24%
121,092
$7,870,980 31 Mar 2024
13F
VOYA INVESTMENT MANAGEMENT LLC
13F
Company
0.23%
116,295
$7,559,175 31 Mar 2024
13F
GREAT POINT PARTNERS LLC
13F
Company
0.23%
115,000
$7,475,000 31 Mar 2024
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.19%
97,381
$6,329,765 31 Mar 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.19%
96,807
$6,292,455 31 Mar 2024
13F
AXA S.A.
13F
Company
0.19%
94,957
$6,172,205 31 Mar 2024
13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
0.19%
94,117
$6,117,605 31 Mar 2024
13F
Qube Research & Technologies Ltd
13F
Company
0.18%
91,997
$5,979,805 31 Mar 2024
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
0.18%
88,750
$5,768,750 31 Mar 2024
13F
Pier Capital, LLC
13F
Company
0.17%
88,054
$5,723,510 31 Mar 2024
13F
Allspring Global Investments Holdings, LLC
13F
Company
0.17%
87,614
$5,694,910 31 Mar 2024
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.17%
86,600
$5,629,000 31 Mar 2024
13F

Institutional Holders of Immunocore Holdings plc - ADR (IMCR) as of Q2 2024

As of 30 Jun 2024, Immunocore Holdings plc - ADR (IMCR) was held by 135 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 43,068,701 shares. The largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, RTW INVESTMENTS, LP, FMR LLC, T. Rowe Price Investment Management, Inc., PRICE T ROWE ASSOCIATES INC /MD/, PRIMECAP MANAGEMENT CO/CA/, BAKER BROS. ADVISORS LP, GENERAL ATLANTIC, L.P., Bellevue Group AG, and ARMISTICE CAPITAL, LLC. This page lists 136 institutional shareholders reporting positions in this security for the Q2 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2024 vs Q1 2024 Across Filers

Q1 2024 holders
149
Q2 2024 holders
135
Holder diff
-14
Investor Q1 2024 Shares Q2 2024 Shares Share Diff Share Chg % Q1 2024 Value $ Q2 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.